secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eloxx Pharmaceuticals, Inc. (ELOX)
CIK:        0001035354
Form:       8-K
Filed at:   2023-06-23T23:59:59+00:00
Accession:  0001104659-23-073875
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Eloxx holders elect all 5 director nominees, ratify auditor, approve say-on-pay
-------------------------------------------------------------------------------

- All five director nominees elected: Kariv (557,994 for), Aggarwal (511,136), Androski (559,991), Rubin (509,103), Walts (559,951).
- Ratification of Baker Tilly as auditor passed with 1,181,736 for, 23,057 against, 48,182 abstain.
- Advisory say-on-pay vote approved: 550,254 for, 12,373 against, 42,508 abstain; 647,840 broker non-votes.
- Approximately 57.83% of outstanding shares were represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1035354/000110465923073875/0001104659-23-073875-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1035354/000110465923073875/tm2319166d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-073875

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer